Abdullah Jalal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abdullah Jalal has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Rami Dali
2 shared publications- Tai Metzger
Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan
2 shared publications Ahmad Suleiman
1 shared publication- Christine Lin
Rush University Medical College, Chicago, IL, 60612
1 shared publication - Diana Mansour1 shared publication
- Emily Jagenburg
School of Medicine, Oakland University, Rochester, USA
1 shared publication
Latest Publications
- 17 September 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-6
Diversity in abdominal radiology: a decade-long review of gender, racial, and ethnic representation among fellows
- 17 September 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-6
Diversity in abdominal radiology: a decade-long review of gender, racial, and ethnic representation among fellows
- Open Access
- 17 August 2026
- Published by Springer Nature in Cureus
- Vol. 18 (8)
Successful Management of a Neonate With Tricuspid Atresia, Double Outlet Right Ventricle, and L-malposed Great Arteries
A neonate with prenatally suspected complex single ventricle physiology was found after birth to have tricuspid atresia with a large ventricular septal defect, double outlet right ventricle, L-malposed great arteries, and severe subpulmonary stenosis. The infant presented at term via cesarean delivery for breech presentation with cyanosis, poor tone, and absent spontaneous respirations, requiring immediate positive pressure ventilation and initiation of prostaglandin E₁ to support ductal patency during hemodynamic stabilization. Early transthoracic echocardiography confirmed complex single ventricle anatomy with a hypoplastic right ventricle, L-malposed great arteries, and a restrictive subpulmonary outflow tract, consistent with a Type IIIb tricuspid atresia subtype with reduced pulmonary blood flow. The patient underwent staged surgical palliation beginning with a 3 mm modified Blalock-Taussig shunt via central sternotomy at one month of age, which was complicated by medically managed necrotizing enterocolitis but otherwise followed by a stable interstage period with appropriate oxygen saturations. The patient had low-normal branch pulmonary arteries, and there was no patent ductus arteriosus. At five and a half months, she underwent a hemi-Fontan procedure with bilateral pulmonary artery patch augmentation, atrial septectomy, and shunt takedown, resulting in a patent cavopulmonary connection and adequate systemic output despite transient postoperative ventricular dysfunction. The child was subsequently discharged on standard heart failure and antiplatelet therapy, with gradual weaning of afterload reduction and diuretics as ventricular function improved and oxygen saturation targets were maintained. This case illustrates how detailed anatomical characterization of tricuspid atresia, particularly the relationship of the great arteries and degree of pulmonary outflow obstruction, guides selection and timing of staged palliation. It also underscores the value of coordinated prenatal and postnatal evaluation, early initiation of prostaglandin therapy, and close interstage monitoring in achieving a favorable early outcome in a rare and complex tricuspid atresia subtype that remains eligible for eventual Fontan completion.
- 17 August 2026
- Published by Springer Nature in Cureus
- Vol. 18 (8)
Open AccessSuccessful Management of a Neonate With Tricuspid Atresia, Double Outlet Right Ventricle, and L-malposed Great Arteries
A neonate with prenatally suspected complex single ventricle physiology was found after birth to have tricuspid atresia with a large ventricular septal defect, double outlet right ventricle, L-malposed great arteries, and severe subpulmonary stenosis. The infant presented at term via cesarean delivery for breech presentation with cyanosis, poor tone, and absent spontaneous respirations, requiring immediate positive pressure ventilation and initiation of prostaglandin E₁ to support ductal patency during hemodynamic stabilization. Early transthoracic echocardiography confirmed complex single ventricle anatomy with a hypoplastic right ventricle, L-malposed great arteries, and a restrictive subpulmonary outflow tract, consistent with a Type IIIb tricuspid atresia subtype with reduced pulmonary blood flow. The patient underwent staged surgical palliation beginning with a 3 mm modified Blalock-Taussig shunt via central sternotomy at one month of age, which was complicated by medically managed necrotizing enterocolitis but otherwise followed by a stable interstage period with appropriate oxygen saturations. The patient had low-normal branch pulmonary arteries, and there was no patent ductus arteriosus. At five and a half months, she underwent a hemi-Fontan procedure with bilateral pulmonary artery patch augmentation, atrial septectomy, and shunt takedown, resulting in a patent cavopulmonary connection and adequate systemic output despite transient postoperative ventricular dysfunction. The child was subsequently discharged on standard heart failure and antiplatelet therapy, with gradual weaning of afterload reduction and diuretics as ventricular function improved and oxygen saturation targets were maintained. This case illustrates how detailed anatomical characterization of tricuspid atresia, particularly the relationship of the great arteries and degree of pulmonary outflow obstruction, guides selection and timing of staged palliation. It also underscores the value of coordinated prenatal and postnatal evaluation, early initiation of prostaglandin therapy, and close interstage monitoring in achieving a favorable early outcome in a rare and complex tricuspid atresia subtype that remains eligible for eventual Fontan completion.
- 1 June 2026
- Published by Beta Beta Biological Society in BIOS
- Vol. 97 (2) , 80-84
Patients, not lab values: ethical reflections on the limits of reductionist biology
- 1 June 2026
- Published by Beta Beta Biological Society in BIOS
- Vol. 97 (2) , 80-84
Patients, not lab values: ethical reflections on the limits of reductionist biology
- Open Access
- 9 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
From GitHub to Clinic? Small-Scale Validation of Open-Source AI for Diabetic Retinopathy Screening (Preprint)
BACKGROUND Accurate, timely detection of diabetic retinopathy (DR) remains challenging, especially in low‑resource settings with limited ophthalmologic expertise. Open‑source deep learning models offer accessible computer vision tools for DR screening, but their real‑world reliability and clinical readiness are not well established. OBJECTIVE This study evaluates two open‑source models—Proliferative Retinopathy Detection and Bhimrazy Diabetic‑Retinopathy‑Detection—on a publicly available Zenodo fundus image dataset to compare performance characteristics and explore potential clinical roles. METHODS We randomly sampled 100 fundus photographs (50 DR‑positive, 50 DR‑negative) from the Zenodo dataset. Each model generated binary predictions (DR vs. no DR) and confidence scores. Using custom Python scripts, we computed sensitivity, specificity, precision, F1 score, accuracy, and average confidence for correctly identified DR‑positive cases. McNemar's test was used to compare paired classification performance between models. RESULTS The Proliferative model achieved 81% accuracy, with precision of 86% and specificity of 0.88, indicating relatively few false positives and greater reliability for ruling out non‑DR cases. Its F1 score was 0.794, with a mean confidence of 78.2% for correctly identified DR‑positive images. The Bhimrazy model demonstrated higher sensitivity (0.88), detecting more DR‑positive cases, but with lower specificity (0.80) and similar precision (81%), reflecting a modest increase in false positives; its F1 score and accuracy were 0.845 and 0.84, respectively. McNemar's test showed no statistically significant difference in overall classification performance between models (χ² = 0.64, p = 0.42). CONCLUSIONS In this small, single‑dataset evaluation, the Proliferative model showed relatively higher specificity and precision, while the Bhimrazy model demonstrated relatively higher sensitivity, yielding complementary operating characteristics rather than clear superiority of one approach. These findings should be viewed as preliminary and hypothesis‑generating. Larger, multi‑center and prospective validations, including assessment across DR severity thresholds and comparison with ophthalmologist performance, are needed before considering any clinical deployment of these open‑source tools. CLINICALTRIAL N/A
- 9 May 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFrom GitHub to Clinic? Small-Scale Validation of Open-Source AI for Diabetic Retinopathy Screening (Preprint)
BACKGROUND Accurate, timely detection of diabetic retinopathy (DR) remains challenging, especially in low‑resource settings with limited ophthalmologic expertise. Open‑source deep learning models offer accessible computer vision tools for DR screening, but their real‑world reliability and clinical readiness are not well established. OBJECTIVE This study evaluates two open‑source models—Proliferative Retinopathy Detection and Bhimrazy Diabetic‑Retinopathy‑Detection—on a publicly available Zenodo fundus image dataset to compare performance characteristics and explore potential clinical roles. METHODS We randomly sampled 100 fundus photographs (50 DR‑positive, 50 DR‑negative) from the Zenodo dataset. Each model generated binary predictions (DR vs. no DR) and confidence scores. Using custom Python scripts, we computed sensitivity, specificity, precision, F1 score, accuracy, and average confidence for correctly identified DR‑positive cases. McNemar's test was used to compare paired classification performance between models. RESULTS The Proliferative model achieved 81% accuracy, with precision of 86% and specificity of 0.88, indicating relatively few false positives and greater reliability for ruling out non‑DR cases. Its F1 score was 0.794, with a mean confidence of 78.2% for correctly identified DR‑positive images. The Bhimrazy model demonstrated higher sensitivity (0.88), detecting more DR‑positive cases, but with lower specificity (0.80) and similar precision (81%), reflecting a modest increase in false positives; its F1 score and accuracy were 0.845 and 0.84, respectively. McNemar's test showed no statistically significant difference in overall classification performance between models (χ² = 0.64, p = 0.42). CONCLUSIONS In this small, single‑dataset evaluation, the Proliferative model showed relatively higher specificity and precision, while the Bhimrazy model demonstrated relatively higher sensitivity, yielding complementary operating characteristics rather than clear superiority of one approach. These findings should be viewed as preliminary and hypothesis‑generating. Larger, multi‑center and prospective validations, including assessment across DR severity thresholds and comparison with ophthalmologist performance, are needed before considering any clinical deployment of these open‑source tools. CLINICALTRIAL N/A
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1) , 3460735
Rare Presentation of Heterozygous PCSK1 Deficiency in an Adolescent Male
Background: Proprotein convertase subtilisin/kexin type 1 (PCSK1) is an enzyme involved in processing prohormones into active peptides. PCSK1 deficiency is a rare genetic condition in which the homozygous presentation has been documented to cause diarrhea during infancy, as well as childhood obesity, high levels of proinsulin, and diverse endocrine abnormalities. Case Description: An eleven‐year‐old male was evaluated in the pediatric cardiology clinic for hypertriglyceridemia and rapid weight gain. He had recently been diagnosed with heterozygous PCSK1 deficiency, defined as c.661A > G, which is predicted to result in the amino acid substitution p.Asn221Asp. The patient reported regular hyperphagia to the point of nausea, with a diet of processed and sugary foods. Past medical history included obstructive sleep apnea and migraines. Physical examination was unremarkable aside from severe obesity (BMI 39.7 kg/m 2 ) and elevated blood pressure. His fasting lipid panel showed elevated triglycerides (330 mg/dL), low HDL (38 mg/dL), normal LDL (71 mg/dL), elevated total cholesterol (175 mg/dL), and normal HbA1c (5.0%). The patient was counseled on lifestyle modifications with the weight management clinic and began a structured weight loss program along with discussions of possible GLP‐1 agonist initiation. Follow‐up lipid monitoring was planned in 3 months after the cardiology clinic visit. Discussion: This case of a heterozygous PCSK1 variant may demonstrate an association between this variant and the patient’s clinical presentation, possibly expanding the known clinical spectrum of the disorder beyond the previously reported presentations in homozygous cases. Our case may show how heterozygous presentations with this variant of PCSK1 deficiency demonstrate a different presentation from the homozygous phenotype in younger patients. This patient shows that PCSK1 abnormalities could have an association with individuals who have hyperphagia and significant obesity, but normal HbA1c and LDL levels. Additional studies could be considered to evaluate prevalence in the population, long‐term outcomes, and targeted therapies.
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1) , 3460735
Open AccessRare Presentation of Heterozygous PCSK1 Deficiency in an Adolescent Male
Background: Proprotein convertase subtilisin/kexin type 1 (PCSK1) is an enzyme involved in processing prohormones into active peptides. PCSK1 deficiency is a rare genetic condition in which the homozygous presentation has been documented to cause diarrhea during infancy, as well as childhood obesity, high levels of proinsulin, and diverse endocrine abnormalities. Case Description: An eleven‐year‐old male was evaluated in the pediatric cardiology clinic for hypertriglyceridemia and rapid weight gain. He had recently been diagnosed with heterozygous PCSK1 deficiency, defined as c.661A > G, which is predicted to result in the amino acid substitution p.Asn221Asp. The patient reported regular hyperphagia to the point of nausea, with a diet of processed and sugary foods. Past medical history included obstructive sleep apnea and migraines. Physical examination was unremarkable aside from severe obesity (BMI 39.7 kg/m 2 ) and elevated blood pressure. His fasting lipid panel showed elevated triglycerides (330 mg/dL), low HDL (38 mg/dL), normal LDL (71 mg/dL), elevated total cholesterol (175 mg/dL), and normal HbA1c (5.0%). The patient was counseled on lifestyle modifications with the weight management clinic and began a structured weight loss program along with discussions of possible GLP‐1 agonist initiation. Follow‐up lipid monitoring was planned in 3 months after the cardiology clinic visit. Discussion: This case of a heterozygous PCSK1 variant may demonstrate an association between this variant and the patient’s clinical presentation, possibly expanding the known clinical spectrum of the disorder beyond the previously reported presentations in homozygous cases. Our case may show how heterozygous presentations with this variant of PCSK1 deficiency demonstrate a different presentation from the homozygous phenotype in younger patients. This patient shows that PCSK1 abnormalities could have an association with individuals who have hyperphagia and significant obesity, but normal HbA1c and LDL levels. Additional studies could be considered to evaluate prevalence in the population, long‐term outcomes, and targeted therapies.